2009
DOI: 10.1111/j.1365-2249.2009.03965.x
|View full text |Cite
|
Sign up to set email alerts
|

T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients

Abstract: There are increased numbers of activated T lymphocytes in the bronchial mucosa of stable chronic obstructive pulmonary disease (COPD) patients. T helper type 17 (Th17) cells release interleukin (IL)-17 as their effector cytokine under the control of IL-22 and IL-23. Furthermore, Th17 numbers are increased in some chronic inflammatory conditions. To investigate the expression of interleukin (IL)-17A, IL-17F, IL-21, IL-22 and IL-23 and of retinoic orphan receptor RORC2, a marker of Th17 cells, in bronchial biops… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

17
251
3
6

Year Published

2010
2010
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 290 publications
(277 citation statements)
references
References 35 publications
17
251
3
6
Order By: Relevance
“…Expression of RORgT is a hallmark of Th17 development (8). Increased RORgT mRNA levels are associated with several human pathologies related to the presence of Th17-driven inflammatory processes (22,41). Our observations of USF-1-and USF-2-mediated RORgT expression in human lymphocytes raise the question of what role these transcription factors may play in Th17 development.…”
Section: Discussionmentioning
confidence: 76%
“…Expression of RORgT is a hallmark of Th17 development (8). Increased RORgT mRNA levels are associated with several human pathologies related to the presence of Th17-driven inflammatory processes (22,41). Our observations of USF-1-and USF-2-mediated RORgT expression in human lymphocytes raise the question of what role these transcription factors may play in Th17 development.…”
Section: Discussionmentioning
confidence: 76%
“…Although IL-17 has already been implicated in inflammatory lung disorders of humans [22][23][24][25][26], and IL-17 and/or IL-17 mRNA has been detected locally in these disorders, the presence of IL-17-containing memory Th cells has not previously been demonstrated in association with increased IL-17 production in the human lungs. The phenotype of the IL-17-containing T-cells demonstrated in the present study resembles what has previously been described for Th17 cells [7,10,27] with respect to these cells being CD4 + memory cells.…”
Section: Increase In Effector Molecules Downstream Of Il-17 and Il-22mentioning
confidence: 96%
“…The role of IL-22 in the development of lung disease is not well understood (64,65). The expression of IL-22 as well as IL-17 is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients (64), suggesting that IL-22 plays some role in the airway inflammation.…”
Section: Discussionmentioning
confidence: 99%